Literature DB >> 8585019

Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides.

M C Chang1, B R Wang, T F Huang.   

Abstract

We investigated the adhesion of human umbilical vein endothelial cells (HUVECs) to fibrin(ogen) molecule of varying structure for identifying sites that mediate cell attachment. Fibrin was prepared either with ancrod which liberates only FPA from fibrinogen, or with thrombin, which liberates both FPA and FPB. Both fibrin preparations equally supported HUVEC attachment. GRGDS, RGD-containing peptides of snake venoms, and monoclonal antibodies against alpha v beta 3 (23C6 and 7E3) inhibited the attachment of HUVECs to fibrin by 65-75%. In contrast, the attachment of HUVECs to fibrinogen was less effective and was almost completely inhibited by both RGD-containing peptides and by antibodies against integrin alpha v beta 3 (85-95% inhibition). The C-terminal dodecapeptide of fibrinogen gamma chain (residues 400-411) inhibited minimally the attachment of HUVECs to fibrin. Additionally, the binding of RGD-containing snake venom peptides to HUVECs was both RGD- and divalent-cation-dependent. The IC50S for inhibition of HUVEC attachment to fibrin were 0.09 microM (rhodostomin), 1.54 microM (trigramin) and 1.64 microM (halysin). These results indicate that fibrin mediated support of cell attachment is independent of the cleavage of FPB from fibrinogen. HUVEC attachment to fibrinogen was almost completely inhibited by RGD-containing peptides and by antibodies against alpha v beta 3. In contrast, the attachment to fibrin was partially resistant to RGD-containing peptides and to the monoclonal antibodies against integrin alpha v beta 3. However, alpha v beta 3 is the major receptor mediating HUVEC attachment to fibrin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585019

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.

Authors:  M E Kroon; P Koolwijk; H van Goor; U H Weidle; A Collen; G van der Pluijm; V W van Hinsbergh
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  A cyclic-RGD-BioShuttle functionalized with TMZ by DARinv "Click Chemistry" targeted to αvβ3 integrin for therapy.

Authors:  Klaus Braun; Manfred Wiessler; Rüdiger Pipkorn; Volker Ehemann; Tobias Bäuerle; Heinz Fleischhacker; Gabriele Müller; Peter Lorenz; Waldemar Waldeck
Journal:  Int J Med Sci       Date:  2010-09-21       Impact factor: 3.738

3.  Adhesion of microvascular endothelial cells to metallic implant surfaces.

Authors:  R A Smith; M W Mosesson; A U Daniels; T K Gartner
Journal:  J Mater Sci Mater Med       Date:  2000-05       Impact factor: 3.896

4.  Remodeling of fibrinogen by endothelial cells in dependence on fibronectin matrix assembly. Effect of substratum wettability.

Authors:  Rumiana Tzoneva; Thomas Groth; George Altankov; Dieter Paul
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

5.  Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.

Authors:  Robert A Campbell; Katherine A Overmyer; Craig H Selzman; Brett C Sheridan; Alisa S Wolberg
Journal:  Blood       Date:  2009-10-01       Impact factor: 22.113

Review 6.  From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.

Authors:  Yu-Ju Kuo; Ching-Hu Chung; Tur-Fu Huang
Journal:  Toxins (Basel)       Date:  2019-06-26       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.